COVID
Showing NaN - NaN of 10
COVID, Corona Virus Infection, Adverse Event Trial in New York (EPIC risk score display)
Completed
- COVID
- +2 more
- EPIC risk score display
-
New York, New YorkNYU Langone Health
Dec 22, 2022
Myeloproliferative Neoplasms (MPN) and COVID-19
Recruiting
- Myeloproliferative Neoplasm
- COVID
-
New York, New York
- +43 more
Apr 4, 2022
COVID, SARS-CoV2 Infection, Covid19 Trial in Worldwide (Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG), Placebo)
Recruiting
- COVID
- +2 more
- Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
- Placebo
-
Washington, District of Columbia
- +37 more
Mar 25, 2022
COVID, Coronavirus Infection Trial in New York (Chloroquine, Placebo oral tablet)
Terminated
- COVID
- Coronavirus Infection
- Chloroquine
- Placebo oral tablet
-
New York, New YorkColumbia University Irving Medical Center/NYP
Jan 10, 2022
COVID, ARDS Trial in United States (PLX-PAD, Placebo)
Active, not recruiting
- COVID
- ARDS
- PLX-PAD
- Placebo
-
Irvine, California
- +12 more
Jan 9, 2022
Sars-CoV2, COVID Trial in United States (Enoxaparin, Prophylactic/Intermediate Dose Enoxaparin)
Completed
- Sars-CoV2
- COVID
- Enoxaparin
- Prophylactic/Intermediate Dose Enoxaparin
-
Newark, New Jersey
- +5 more
Nov 17, 2021
COVID-19, COVID, Coronavirus Trial in New York (Continuous Positive Airway Pressure)
Terminated
- COVID-19
- +2 more
- Continuous Positive Airway Pressure
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 12, 2021
Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)
Recruiting
- Cancer, Metastatic
- +42 more
- Clinical Trial Matching
-
New York, New YorkMassive Bio, Inc
May 21, 2021